The FDA has notified consumers not to purchase or consume Celerite Slimming Capsules, a weight loss product. FDA laboratory analysis has found that Celerite Slimming Capsules contain sibutramine, a controlled substance that was withdrawn from the market in October 2010. Celerite Slimming Capsules pose a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke.  This product may also interact in life threatening ways with other medications a consumer may be taking.

Consumers who have Celerite Slimming Capsules in their possession should stop using it immediately and contact their healthcare provider if they experience any adverse effects.

For more information visit